Liver Disease Diagnostics by Immunoblot Test System
Liver-9-Line facilitates the rapid and cost-effective diagnosis of autoimmune hepatitis (type 1 and type 2 AIH) and primary biliary cirrhosis (PBC) in a single step. The test system also allows for the reliable differentiation of these autoimmune diseases from other diseases of the liver. This immunoblot is suitable for initial and differential diagnosis in cases of ambiguous symptomatology or for differentiation of a positive result from screening carried out with ELISA or immunofluorescence tests.
The comprehensive set of antigens included in this new immunoblot is unique on the market: In addition to the three ASMAs, F-actin, myosin, and desmin, Liver-9-Line also detects antibodies against soluble liver antigen (SLA/LP), liver kidney microsomal type 1 (LKM-1), and liver cytosol antigen type 1 (LC1). The PBC-typical autoantibodies detected by this immunoblot include AMA-M2 as well as antibodies against Sp100 and gp210.
The analytical software from ORGENTEC Diagnostika allows for the automated evaluation of the immunoblots. The iVISION Scanware makes it possible to objectively analyze and securely archive test data.
Overview of the antigens used in the Liver-9-Line test: M2, Sp100, gp210, SLA/LP, LKM-1, LC1, F-actin, desmin, myosin. Liver-9-Line is available in packages of 8 or 16 immunoblot strips, all reagents are ready for immediate use. Each individual blot strip includes serum, conjugate control, and cut-off control, as well as an individual code that eliminates accidental mix-ups. - www.orgentec.com
About ORGENTEC Diagnostika:
ORGENTEC Diagnostika GmbH is based in Mainz and is a global leader in the development, production, and marketing of test systems for laboratory diagnostics. ORGENTEC Diagnostika has developed over 200 different test systems for autoimmune diagnostics and the diagnosis of infectious disease. Many of these tests are patent-protected. At the company’s headquarters in Mainz, ORGENTEC Diagnostika now employs over 120 people. With its own distribution channels in Germany, Austria, Switzerland, Hungary, and France, as well as an established global distribution network, ORGENTEC Diagnostika’s products and laboratory tests are benefitting patients in over 100 countries around the world. - www.orgentec.com
ORGENTEC Diagnostika GmbH
- Public Relations -
Dr. Friederike Hammar
55129 Mainz, GERMANY
Tel. +49 6131 9258-677, -674
Fax +49 6131 9258-58
ORGENTEC’s media channels:
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Disease Diagnostics by Immunoblot Test System here
News-ID: 175251 • Views: 2855
More Releases from ORGENTEC Diagnostika
Fully Automated Chlamydia Diagnostics from ORGENTEC
Mainz, June 19, 2012 – ORGENTEC Diagnostika (www.orgentec.com) has introduced six new tests for the diagnosis of infectious diseases. The new ELISA tests detect antibodies against Chlamydia trachomatis and Chlamydia pneumoniae. In addition, these test systems make it possible to differentiate between acute, latent, and chronic infection with these widespread bacterial pathogens. The new tests for the serological diagnosis of Chlamydia were developed specifically for Alegria®, ORGENTEC Diagnostika’s random access analyser.
Online Immunofluorescence Guide for Diagnosis of Autoimmune Diseases
Mainz, May 09 2012 – From now on the Immunofluorescence Guide for the Modern Autoimmunity Laboratory is available as a free ebook. The online reference work with numerous pictures of immunofluorescence patterns is accessible from the ORGENTEC Diagnostika website (www.orgentec.com) and from the website of the GRÜNE CLUB AUTOIMMUN (www.der-gruene-club.at). The online guide is public domain without login or registration. Whether it is the immunofluorescence pattern of antinuclear antibodies (ANA) on
Autoantibody Diagnostics in Autoimmune Liver Diseases
ORGENTEC Diagnostika (www.orgentec.com) has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. These tests are now on the market. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®. The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these
A New Healthcare App: ORGENTEC Autoimmunity Guide
The ORGENTEC Autoimmunity Guide is now available for download from the Apple iTunes App Store and the Android Market. This app from Mainz-based ORGENTEC Diagnostika GmbH (www.orgentec.com) makes it possible to call up information about autoimmune diseases easily and comfortably from a smartphone or tablet – precisely, compactly, and without extensive searching. The ORGENTEC app offers comprehensive information about the diagnosis and monitoring of autoimmune diseases by means of antibody detection.
More Releases for Mainz
Solar Photovoltaic in Germany Market Insights to 2030 by Top Players UniCredit B …
Solar Photovoltaic (PV) in Germany, Market Outlook to 2030, Update 2017-Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Germany, Market Outlook to 2030, Update 2017-Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Germany. Get Sample
TRON receives three-year research grant from the Falconwood Foundation to develo …
Mainz, February 14, 2018 - TRON (Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, Germany), an internationally recognized leader in tumor immunology and cancer therapy research, has announced a three-year grant from the Falconwood Foundation, New York, USA, totalling 3 Million Euros. The grant supports the launch of a new research project to identify biomarkers specific for neuroendocrine tumors (NETs) that are crucial for the
Prof. Dr. Cornelis Melief Receives Honorary Doctorate from Johannes Gutenberg Un …
- Ceremony Conventio Medicinae held at University Medical Center Leiden, The Netherlands, October 26, 2017 – ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced that its Chief Scientific Officer, Prof. Cornelis Melief, has received an honorary doctorate from the University Medical Center of Johannes Gutenberg University Mainz, Germany. The honorary doctorate was awarded during a festive ceremony in Mainz on October 25, 2017. Prof. Melief was recognized for his lifetime achievements
Research project by iba AG and the Johannes Gutenberg University in Mainz
Flat products in metal processing industry are produced in several steps. The individual process steps are usually not interconnected directly, but are separated by transportation routes and interim storage facilities. When the coils are supplied to the next process step, they might be mixed up. For identifying the coils, iba AG has developed in cooperation with the Johannes Gutenberg University in Mainz mathematical algorithms and processes that are based on
Coface Arena: Back Straight Becomes ORGENTEC Stands
The Mainz-based company ORGENTEC Diagnostika has extended its involvement with 1. FSV Mainz 05 and will continue to sponsor stands at the new Coface Arena in Mainz. As they did in the Bruchweg Stadium, the globally active company, which specializes in laboratory tests, will keep the naming rights for the back straight in the new stadium built for FSV Mainz 05 for three years. In addition, ORGENTEC Diagnostika will have a
iVISION Scanware: Automated Evaluation of Immunoblots
Mainz, 06/12/2010 – With the introduction of iVISION Scanware, ORGENTEC Diagnostika has made it possible to automate the evaluation of immunoblots. The software allows these effective and robust test systems to be objectively assessed and the laboratory test results efficiently stored and archived. By graphically representing test results, the software very effectively aids physicians and laboratory personnel in interpreting results and makes it possible to obtain a diagnosis within a few